发明名称 |
Compositions comprising nicotinic agonists and methods of using same |
摘要 |
The disclosure is directed at least in part to compositions and methods comprising nicotinic agonists for treating e.g., nervous system disorders, in particular, to combination therapies that include a nicotinic agonist (for example, nicotine) and a nicotinic acetylcholine receptor desensitization inhibitor (for example, opipramol). |
申请公布号 |
US8921356(B2) |
申请公布日期 |
2014.12.30 |
申请号 |
US201213593911 |
申请日期 |
2012.08.24 |
申请人 |
NeuroDerm, Ltd. |
发明人 |
Heldman Eliahu |
分类号 |
A61K31/55;A61K31/465;A61K31/167;A61K31/27;A61K31/4406 |
主分类号 |
A61K31/55 |
代理机构 |
Goodwin Procter LLP |
代理人 |
Goodwin Procter LLP |
主权项 |
1. A method for treatment of attention deficit hyperactivity disorder (ADHD) or attention deficit disorder (ADD) comprising co-administering to a patient in need thereof a therapeutically effective amount of (a) nicotine, or a pharmaceutically acceptable salt or N-oxide thereof, and (b) opipramol, or a pharmaceutically acceptable salt or ester thereof. |
地址 |
Rehovot IL |